The observation that RvD3 administrations can prevent not only psoriasiform skin inflammation but also psoriasiform itch (i.e. spontaneous itch and alloknesis), supports a role for TRPV1-expressing neurons in psoriasis and the therapeutic importance of targeting neuroimmune mechanisms in this disorder. The gene discussed is TRPV1; the disease is psoriasis.